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LETTERS TO EDITOR 
BACKTABLE ANGIOSCOPY TO EVALUATE THE RENAL ARTERYl 
Pathological conditions of the intima due to trauma or exist-
ing donor pathology can result in arterial thrombosis after 
transplantation (1). We recently encountered a case where a 
question was raised about the condition of the donor renal 
artery, in which angioscopic examination was used to establish 
that the artery was satisfactory. The kidney was from a 58-
year-old donor who died of an intracranial hemorrhage. Organ 
recovery was uneventful. On backtable examination of the renal 
artery there appeared to be intramural hemorrhage and the 
possibility of an intimal dissection. 
We used a 2.2-mm angioscope (Olympus Angiofiberscope 
PF22) that was easily directed into the distal renal artery. The 
cold UW preservation solution in which the kidney was im-
mersed provided a perfect bloodless field. During withdrawal 
of the angioscope, a clear view of the wall of the renal artery 
was obtained. A small proximal artherosclerotic plaque was 
noted near the orifice to the aorta. There was no evidence of 
intimal tear. The procedure lasted less than 10 min. The kidney 
was transplanted without technical complications. 
The development of angioscopy has been one of the recent 
advances in vascular surgery (2). Angioscopes can be readily 
used in transplantation, as was shown in this case. The advan-
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tages of backtable angioscopy include simplicity and rapidity 
of diagnosis in a bloodless, easily accessible field, as well as 
accuracy for pinpointing the potential intimal pathology, as the 
light of the angioscope can be seen through the wall of the 
vessel. To our knowledge, angioscopy has not been used previ-
ously in transplantation. 
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THE CHACMA BABOON AS AN ORGAN DONOR FOR MAN 
The recent article by Jennifer Stark and her colleagues from 
Johannesburg (Transplantation 1991; 52; 107) reporting studies 
exploring immunologic compatibility between the Chacma ba-
boon and man was of considerable interest. Their statement, 
however, that "in concordant xenotransplantation, the rejec-
tion process mimics that seen in human allografts" is not 
entirely supported by the few studies that have been performed. 
Using the vervet (African green) monkey-to-baboon heter-
otopic cardiac transplant model, which involves two Old World 
monkeys that would appear to be phylogenetically closer than 
the baboon and man, the Cape Town group noted that, although 
graft survival extended for a mean of 10 days, approximately 
80% of the hearts of nonimmunosuppressed baboons showed 
features consistent with vascular (antibody-mediated) or mixed 
cellular and vascular rejection (1). Furthermore, triple-drug 
therapy consisting of cyclosporine, azathioprine, and methyl-
prednisolone did not extend survival significantly (2). By in-
creasing the immunosuppressive therapy even further by the 
addition of induction ATG or 15-deoxyspergualin and bolus 
methylprednisolone for rejection, some prolongation of graft 
survival was obtained, but at the cost of increased infection 
and other complications (3). 
longed survival of heterotopic cynomolgus-to-baboon hearts (4, 
5), they could not demonstrate significantly increased survival 
of orthotopically transplanted cynomolgus monkey hearts in 
baboons despite quadruple-drug immunosuppression (5). A 
note of optimism is provided by Panza et a1. (6) who-in the 
same animal model but utilizing a combination of total lymph-
oid irradiation, cyclosporine, and steroids-achieved survival 
of heterotopic heart transplants beyond one year; in view of 
the Columbia-Presbyterian experience, however, this result 
must be viewed with some caution. The Johannesburg group, 
with its unique experience with TLI in renal allografting is, of 
course, in an ideal position to explore this approach further. 
The authors imply that ABO incompatibility played a major 
role in the development of severe rejection episodes "in the 
majority of baboon-man xenotransplants reported." This may 
well have been so, although the addition of ABO incompatibility 
in the Cape Town vervet-to-baboon xenografts did not result 
in an increased incidence of histopathological features of vas-
cular rejection, though there may have been an increased inci-
dence of early hyperacute rejection (1, 2). From this study it 
would seem that xenoreactive antibodies playa more important 
role than anti·ABO antibodies. 
Although the Columbia-Presbyterian group reported pro-
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